Should all patients with serous and clear cell endometrial carcinoma receive adjuvant chemotherapy? (Q39811675)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21118038%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Should all patients with serous and clear cell endometrial carcinoma receive adjuvant chemotherapy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21118038%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

main subject

endometrial carcinoma

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21118038%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Todd P Boren

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21118038%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21118038%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21118038%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21118038%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21118038%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

789-795

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21118038%20AND%20SRC:MED&resulttype=core&format=json

The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study

17 January 2020

cites work

1 reference

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

21 January 2018

1 reference

Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths.

21 January 2018

1 reference

Clear cell carcinoma of the endometrium: a histopathological and clinical study of 97 cases

21 January 2018

1 reference

The effect of age on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer

21 January 2018

1 reference

Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium

21 January 2018

1 reference

Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases

21 January 2018

1 reference

Phase III trial of doxorubicin plus cisplatin with or without paclitaxel plus filgrastim in advanced endometrial carcinoma: a Gynecologic Oncology Group Study

21 January 2018

1 reference

A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study

21 January 2018

1 reference

Phase III trial of doxorubicin with or without cisplatin in advanced endometrial carcinoma: a gynecologic oncology group study

21 January 2018

1 reference

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer

21 January 2018

1 reference

Paclitaxel and carboplatin in the adjuvant treatment of patients with high-risk stage III and IV endometrial cancer: a retrospective study

21 January 2018

1 reference

Treatment of uterine papillary serous carcinoma with platinum-based chemotherapy and paclitaxel

21 January 2018

1 reference

Paclitaxel and carboplatin, alone or with irradiation, in advanced or recurrent endometrial cancer: a phase II study

21 January 2018

1 reference

Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma

21 January 2018

1 reference

Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma

21 January 2018

1 reference

Surgical management and adjuvant therapy for patients with uterine clear cell carcinoma: a multi-institutional review

21 January 2018

1 reference

Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma

21 January 2018

1 reference

Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation

21 January 2018

1 reference

The efficacy of adjuvant platinum-based chemotherapy in Stage I uterine papillary serous carcinoma (UPSC).

21 January 2018

1 reference

Role of systematic lymphadenectomy and adjuvant therapy in stage I uterine papillary serous carcinoma

21 January 2018

1 reference

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy

21 January 2018

1 reference

Platinum/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma

21 January 2018

1 reference

An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC).

21 January 2018

1 reference

Outcome and patterns of failure in pathologic stages I-IV clear-cell carcinoma of the endometrium: implications for adjuvant radiation therapy

21 January 2018

1 reference

Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma

21 January 2018

1 reference

Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis

21 January 2018

1 reference

Phase III randomized trial of doxorubicin + cisplatin versus doxorubicin + 24-h paclitaxel + filgrastim in endometrial carcinoma: a Gynecologic Oncology Group study

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/WHE.10.64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21118038%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21118038%20AND%20SRC:MED&resulttype=core&format=json